Journal of Pediatric Neurology 2021; 19(06): 409-413
DOI: 10.1055/s-0040-1718697
Original Article

Association between Childhood Allergic Diseases and Headache

1   Department of Pediatrics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand
,
Suwannee Uthaisangsook
1   Department of Pediatrics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand
,
Nadda Padsee
1   Department of Pediatrics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand
,
Klaita Srisingh
1   Department of Pediatrics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand
› Author Affiliations
Funding This work was financially supported by a research grant from the Faculty of Medicine, Naresuan University (grant no. R2562C006).

Abstract

Allergic disorders and headache are both common in pediatric populations. Chronic allergic disorders may affect sleep leading to chronic daily headaches. Poor controlled allergies may cause neurogenic inflammation that may be a predisposing factor to migraine headaches. We hypothesized that a higher prevalence of headaches may be found in children with allergy compared with those without allergy. Patients with either multiple allergic disorders or with poorly controlled allergic symptoms may be associated with headaches, especially migraine headaches. This study aimed to examine (1) the prevalence of headache in allergic children and (2) the association between allergic diseases and headache. Patients with allergic diseases and nonallergic children as control were recruited in the pediatric outpatient clinic of Naresuan University Hospital between January 2017 and January 2018. A neurological examination was performed by a pediatric neurologist. The questionnaire consisted of the pediatric headache symptom checklist and the items for evaluation of allergy control status. The diagnosis and classification of headache were based on the International Classification of Headache Disorders-3 criteria. The results were analyzed using the Student's t-test, chi-squared tests, odds ratios, and 95% confidence interval. One hundred fifty-five subjects were enrolled in our study, of which 85 subjects (54.8%) were diagnosed with allergic diseases. The allergic group had a significantly higher prevalence of headache than the control group (37 [43.5%] vs. 19 [27.1%], p = 0.035). The allergic group also had a significantly higher prevalence of migraine and probable migraine headache than the control group (23 [27.06%] vs. 7 [10%], p = 0.007). The prevalence of headache did not increase in subjects who had more than one allergic disease. There was no association between the control of allergy and headache. The present study showed that allergic diseases were associated with increased prevalence of headache and migraine in children. However, the control of allergic symptoms and the number of allergic diseases were not associated with headache. The physicians should be aware of headache in allergic patients and give appropriate treatment. Further study would be to identify specific biomarkers for the development of better treatment in these comorbid diseases.



Publication History

Received: 24 July 2020

Accepted: 11 September 2020

Article published online:
15 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Pols DHJ, Wartna JB, Moed H, van Alphen EI, Bohnen AM, Bindels PJ. Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: a systematic review. Scand J Prim Health Care 2016; 34 (02) 143-150
  • 2 Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep 2013; 17 (06) 341
  • 3 Nodari E, Battistella PA, Naccarella C, Vidi M. Quality of life in young Italian patients with primary headache. Headache 2002; 42 (04) 268-274
  • 4 Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics 2003; 112 (1 Pt 1): e1-e5
  • 5 Vallesi A. On the utility of the trail making test in migraine with and without aura: a meta-analysis. J Headache Pain 2020; 21 (01) 63
  • 6 Gungen AC, Gungen B. Assessment of headache in asthma patients. Pak J Med Sci 2017; 33 (01) 156-161
  • 7 Silverberg JI. Association between childhood eczema and headaches: an analysis of 19 US population-based studies. J Allergy Clin Immunol 2016; 137 (02) 492-499.e5
  • 8 Ku M, Silverman B, Prifti N, Ying W, Persaud Y, Schneider A. Prevalence of migraine headaches in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97 (02) 226-230
  • 9 Straube A, Heinen F, Ebinger F, von Kries R. Headache in school children: prevalence and risk factors. Dtsch Arztebl Int 2013; 110 (48) 811-818
  • 10 Forcelini C, Ramos M, Santos IFD. et al. The influence of allergic rhinoconjunctivitis on migraine disability in children. Arq Neuropsiquiatr 2019; 77 (06) 418-423
  • 11 Özge A, Uluduz D, Bolay H. Co-occurrence of migraine and atopy in children and adolescents: myth or a casual relationship?. Curr Opin Neurol 2017; 30 (03) 287-291
  • 12 Terwindt GM, Ferrari MD, Launer LJ. The impact of headache on quality of life. J Headache Pain 2003; 4 (01) 35-41
  • 13 Dirican N, Demirci S, Cakir M. The relationship between migraine headache and asthma features. Acta Neurol Belg 2017; 117 (02) 531-536
  • 14 Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel) 2010; 3 (03) 514-540
  • 15 Miller VA, Palermo TM, Powers SW, Scher MS, Hershey AD. Migraine headaches and sleep disturbances in children. Headache 2003; 43 (04) 362-368
  • 16 Rabner J, Kaczynski KJ, Simons LE, LeBel A. Pediatric headache and sleep disturbance: a comparison of diagnostic groups. Headache 2018; 58 (02) 217-228
  • 17 Bektas H, Karabulut H, Doganay B, Acar B. Allergens might trigger migraine attacks. Acta Neurol Belg 2017; 117 (01) 91-95
  • 18 Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005; 45 (Suppl. 01) S3-S13
  • 19 Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130 (1-2): 166-176
  • 20 Aich A, Afrin LB, Gupta K. Mast cell-mediated mechanisms of nociception. Int J Mol Sci 2015; 16 (12) 29069-29092
  • 21 Clark D, Hough H, Wolff HG. Experimental studies on headache: observations on headache produced by histamine. Arch Neurol Psychiatry 1936; 35: 1054-1069
  • 22 Krabbe AA, Olesen J. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 1980; 8 (02) 253-259
  • 23 Anthony M, Lord GD, Lance JW. Controlled trials of cimetidine in migraine and cluster headache. Headache 1978; 18 (05) 261-264
  • 24 Yuan H, Silberstein SD. Histamine and migraine. Headache 2018; 58 (01) 184-193